Document is current
Any future updates will be listed below
-
Authors
Buissant des Amorie, Julian R.
Betjes, Max A.
Bernink, Jochem H. https://orcid.org/0000-0001-9332-9224
Hageman, Joris H. https://orcid.org/0000-0002-1386-054X
Geurts, Veerle E.
Begthel, Harry
Laskaris, Dimitrios
Heinz, Maria C. https://orcid.org/0000-0003-2866-9155
Jordens, Ingrid https://orcid.org/0000-0001-7865-2816
Vinck, Tiba
Houtekamer, Ronja M.
Verlaan-Klink, Ingrid
Brunner, Sascha R.
van Rheenen, Jacco https://orcid.org/0000-0001-8175-1647
Gloerich, Martijn https://orcid.org/0000-0002-0034-4642
Clevers, Hans https://orcid.org/0000-0002-3077-5582
Tans, Sander J.
van Zon, Jeroen S.
Snippert, Hugo J. G. https://orcid.org/0000-0002-4189-5213
- License Information
-
More Information
Article History
Received: 1 October 2024
Accepted: 3 July 2025
First Online: 22 July 2025
Competing interests
: H.C. is the head of Pharma Research and Early Development at Roche, Basel, and holds several patents related to organoid technology. The full disclosure is given at . The other authors declare no competing interests.
